| Year |
Citation |
Score |
| 2020 |
Upshaw JN, Hubbard RA, Hu J, Brown JC, Smith AM, Demissei B, Schmitz KH, Ky B. Physical activity during and after breast cancer therapy and associations of baseline physical activity with changes in cardiac function by echocardiogram. Cancer Medicine. PMID 32645252 DOI: 10.1002/Cam4.3277 |
0.328 |
|
| 2020 |
Conant EF, Zuckerman SP, McDonald ES, Weinstein SP, Korhonen KE, Birnbaum JA, Tobey JD, Schnall MD, Hubbard RA. Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round. Radiology. 191751. PMID 32154771 DOI: 10.1148/Radiol.2020191751 |
0.376 |
|
| 2020 |
Demissei BG, Hubbard RA, Zhang L, Smith AM, Sheline K, McDonald C, Narayan V, Domchek SM, DeMichele A, Shah P, Clark AS, Fox K, Matro J, Bradbury AR, Knollman H, et al. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction. Journal of the American Heart Association. 9: e014708. PMID 31959034 DOI: 10.1161/Jaha.119.014708 |
0.339 |
|
| 2020 |
Demissei BG, Adusumalli S, Denduluri S, Hubbard RA, Getz K, Narayan V, Clark AS, Shah P, Knollman H, Carver JR, Ky B. CARDIOLOGIST INVOLVEMENT IN BREAST CANCER PATIENTS TREATED WITH TRASTUZUMAB-BASED CANCER THERAPY REGIMEN Journal of the American College of Cardiology. 75: 1053. DOI: 10.1016/S0735-1097(20)31680-6 |
0.362 |
|
| 2019 |
Ibáñez-Sanz G, Garcia M, Milà N, Hubbard RA, Vidal C, Binefa G, Benito L, Moreno V. False-positive results in a population-based colorectal screening programme: cumulative risk from 2000 to 2017 with biennial screening. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31488415 DOI: 10.1158/1055-9965.Epi-18-1368 |
0.318 |
|
| 2019 |
Demissei BG, Finkelman BS, Hubbard RA, Zhang L, Smith AM, Sheline K, McDonald C, Narayan HK, Narayan V, Waxman AJ, Domchek SM, DeMichele A, Shah P, Clark AS, Bradbury AR, et al. Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy. Cancer. PMID 31042319 DOI: 10.1002/Cncr.32149 |
0.329 |
|
| 2019 |
Bowles EJA, Yu O, Ziebell R, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Boggs JM, Burnett-Hartman AN, Sterrett A, Fujii M, Chubak J. Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study. Bmc Cancer. 19: 270. PMID 30917783 DOI: 10.1186/S12885-019-5493-8 |
0.307 |
|
| 2019 |
Pocobelli G, Yu O, Ziebell RA, Aiello Bowles EJ, Fujii MM, Sterrett AT, Boggs JM, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Chubak J. Use of antidepressants after colon cancer diagnosis and risk of recurrence. Psycho-Oncology. PMID 30703275 DOI: 10.1002/Pon.5015 |
0.33 |
|
| 2019 |
Demissei BG, Finkelman BS, Hubbard RA, Smith AM, Narayan HK, Narayan V, Shah P, Waxman AJ, Domchek SM, Ky B. Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer Therapy. Journal of the American College of Cardiology. 73: 248-249. PMID 30654897 DOI: 10.1016/J.Jacc.2018.10.057 |
0.329 |
|
| 2019 |
McDonald E, Carlin S, Maxwell K, Nayak A, Doot R, Pantel A, Farwell, Pryma D, Clark A, Shah P, DeMichele A, Ziober A, Schubert E, Palmer K, Lee H, ... ... Hubbard R, et al. Abstract PD4-07: PET imaging of PARP-1 expression in breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Pd4-07 |
0.331 |
|
| 2019 |
Upshaw J, Finkelman B, Hubbard R, Smith A, Narayan H, Arndt L, Domchek S, DeMichele A, Fox K, Shah P, Clark A, Bradbury A, Matro J, Adusumalli S, Carver J, et al. CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION WITH CONTEMPORARY BREAST CANCER THERAPY Journal of the American College of Cardiology. 73: 1676. DOI: 10.1016/S0735-1097(19)32282-X |
0.308 |
|
| 2019 |
Demissei B, Hubbard RA, Zhang L, Smith AM, Sheline K, McDonald C, Narayan V, Domchek SM, DeMichele A, Shah P, Clark AS, Fox K, Matro J, Bradbury AR, Knollman H, et al. Changes In Cardiovascular Biomarkers With Breast Cancer Therapy And Associations With Cardiac Dysfunction Journal of the American College of Cardiology. 73: 678. DOI: 10.1016/S0735-1097(19)31286-0 |
0.311 |
|
| 2018 |
Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, Houssami N, Lehman CD, Henderson LM, Hubbard RA. Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017768267. PMID 29718790 DOI: 10.1200/Jco.2017.76.8267 |
0.379 |
|
| 2018 |
Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA. Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Research and Treatment. PMID 29516372 DOI: 10.1007/S10549-018-4732-Z |
0.343 |
|
| 2018 |
Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T. Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. Journal of Women's Health (2002). PMID 29334616 DOI: 10.1089/Jwh.2017.6428 |
0.338 |
|
| 2017 |
Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T. Utilization of breast cancer screening with magnetic resonance imaging in community practice. Journal of General Internal Medicine. PMID 29214373 DOI: 10.1007/S11606-017-4224-6 |
0.359 |
|
| 2017 |
Chubak J, Onega T, Zhu W, Buist DSM, Hubbard RA. An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events. Medical Care. 55: e81-e87. PMID 29135770 DOI: 10.1097/Mlr.0000000000000352 |
0.315 |
|
| 2017 |
Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. Journal of Surgical Oncology. PMID 29127715 DOI: 10.1002/Jso.24796 |
0.323 |
|
| 2017 |
Hubbard RA, Johnson E, Chubak J, Wernli KJ, Kamineni A, Bogart A, Rutter CM. Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models. Health Services & Outcomes Research Methodology. 17: 101-112. PMID 28943779 DOI: 10.1007/S10742-016-0149-5 |
0.326 |
|
| 2017 |
Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, Henderson L, Hill D, Lee CI, Tosteson AN, Onega T. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. Journal of Women's Health (2002). PMID 28177856 DOI: 10.1089/Jwh.2016.6076 |
0.372 |
|
| 2016 |
Goodrich ME, Weiss J, Onega T, Balch SL, Buist DS, Kerlikowske K, Henderson LM, Hubbard RA. The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women. The Breast Journal. PMID 27550072 DOI: 10.1111/Tbj.12651 |
0.379 |
|
| 2016 |
Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, et al. Population-based precision cancer screening: a symposium on evidence, epidemiology, and next steps. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27507769 DOI: 10.1158/1055-9965.Epi-16-0555 |
0.347 |
|
| 2016 |
Hubbard RA, Lange J, Zhang Y, Salim BA, Stroud JR, Inoue LY. Using semi-Markov processes to study timeliness and tests used in the diagnostic evaluation of suspected breast cancer. Statistics in Medicine. PMID 27439856 DOI: 10.1002/Sim.7055 |
0.645 |
|
| 2016 |
Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, O'Donoghue C. Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging. American Journal of Surgery. PMID 27421187 DOI: 10.1016/J.Amjsurg.2016.03.014 |
0.319 |
|
| 2016 |
Hubbard RA, O'Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson AN, Wernli KJ, Onega T. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Preventive Medicine. PMID 27261409 DOI: 10.1016/J.Ypmed.2016.05.034 |
0.343 |
|
| 2016 |
Onega T, Weiss JE, Buist DS, Tosteson AN, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA, Bennette CS, Hubbard RA. Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer. Medical Care. PMID 27111752 DOI: 10.1097/Mlr.0000000000000542 |
0.338 |
|
| 2016 |
Onega T, Lee CI, Benkeser D, Alford-Teaster J, Haas JS, Tosteson AN, Hill D, Shi X, Henderson LM, Hubbard RA. Travel Burden to Breast MRI and Utilization: Are Risk and Sociodemographics Related? Journal of the American College of Radiology : Jacr. PMID 27026577 DOI: 10.1016/J.Jacr.2016.01.022 |
0.342 |
|
| 2016 |
Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. Journal of Medical Screening. PMID 26946420 DOI: 10.1177/0969141316630766 |
0.326 |
|
| 2016 |
Onega T, Tosteson AN, Weiss J, Alford-Teaster J, Hubbard RA, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA. Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis. Bmc Health Services Research. 16: 76. PMID 26920552 DOI: 10.1186/S12913-016-1317-6 |
0.352 |
|
| 2016 |
Alford-Teaster J, Lange JM, Hubbard RA, Lee CI, Haas JS, Shi X, Carlos HA, Henderson L, Hill D, Tosteson AN, Onega T. Is the closest facility the one actually used? An assessment of travel time estimation based on mammography facilities. International Journal of Health Geographics. 15: 8. PMID 26892310 DOI: 10.1186/S12942-016-0039-7 |
0.309 |
|
| 2016 |
Gray SL, Dublin S, Yu O, Walker R, Anderson M, Hubbard RA, Crane PK, Larson EB. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. Bmj (Clinical Research Ed.). 352: i90. PMID 26837813 DOI: 10.1136/Bmj.I90 |
0.312 |
|
| 2016 |
Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ, Hubbard RA. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Annals of Internal Medicine. PMID 26756460 DOI: 10.7326/M15-1241 |
0.372 |
|
| 2016 |
Ripping TM, Hubbard RA, Otten JD, den Heeten GJ, Verbeek AL, Broeders MJ. Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer. International Journal of Cancer. 138: 1619-25. PMID 26537645 DOI: 10.1002/Ijc.29912 |
0.395 |
|
| 2016 |
Wernli K, Arao R, Hubbard R, Sprague B, Alford-Teaster J, Haas J, Henderson L, Hill D, Lee C, Tosteson A, Onega T. How Have Breast Cancer Screening Intervals Changed Since the 2009 USPSTF Guideline Update? Cancer Epidemiology Biomarkers & Prevention. 25: 558-558. DOI: 10.1158/1055-9965.Epi-16-0079 |
0.387 |
|
| 2015 |
Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL. Statistical methods for estimating the cumulative risk of screening mammography outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26721668 DOI: 10.1158/1055-9965.Epi-15-0824 |
0.309 |
|
| 2015 |
Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. PMID 26709819 DOI: 10.1002/Cncr.29805 |
0.37 |
|
| 2015 |
Henderson LM, Hubbard RA, Sprague BL, Zhu W, Kerlikowske K. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26631292 DOI: 10.1158/1055-9965.Epi-15-0623 |
0.378 |
|
| 2015 |
Henderson LM, Weiss J, Hubbard RA, O'Donoghue C, DeMartini WB, Buist DS, Kerlikowske K, Goodrich M, Virnig B, Tosteson AN, Lehman CD, Onega T. Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer. The Breast Journal. PMID 26511204 DOI: 10.1111/Tbj.12522 |
0.349 |
|
| 2015 |
Hubbard RA. US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis. Evidence-Based Medicine. 20: 201. PMID 26351373 DOI: 10.1136/Ebmed-2015-110272 |
0.386 |
|
| 2015 |
Lee CI, Bogart A, Germino JC, Goldman LE, Hubbard RA, Haas JS, Hill DA, Tosteson AN, Alford-Teaster JA, DeMartini WB, Lehman CD, Onega TL. Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations. Journal of Medical Screening. PMID 26078275 DOI: 10.1177/0969141315591616 |
0.343 |
|
| 2015 |
Jacobsen KK, Abraham L, Buist DS, Hubbard RA, O'Meara ES, Sprague BL, Kerlikowske K, Vejborg I, Von Euler-Chelpin M, Njor SH. Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark. Cancer Epidemiology. PMID 26013768 DOI: 10.1016/J.Canep.2015.05.004 |
0.332 |
|
| 2015 |
Lee JM, Buist DS, Houssami N, Dowling EC, Halpern EF, Gazelle GS, Lehman CD, Henderson LM, Hubbard RA. Five-year risk of interval-invasive second breast cancer. Journal of the National Cancer Institute. 107. PMID 25904721 DOI: 10.1093/Jnci/Djv109 |
0.376 |
|
| 2015 |
Lee CI, Bogart A, Hubbard RA, Obadina ET, Hill DA, Haas JS, Tosteson AN, Alford-Teaster JA, Sprague BL, DeMartini WB, Lehman CD, Onega TL. Advanced Breast Imaging Availability by Screening Facility Characteristics. Academic Radiology. 22: 846-52. PMID 25851643 DOI: 10.1016/J.Acra.2015.02.011 |
0.345 |
|
| 2015 |
Chubak J, Hubbard RA, Johnson E, Kamineni A, Rutter CM. Assessing the effectiveness of a cancer screening test in the presence of another screening modality. Journal of Medical Screening. 22: 69-75. PMID 25492942 DOI: 10.1177/0969141314562036 |
0.33 |
|
| 2015 |
Lange JM, Hubbard RA, Inoue LY, Minin VN. A joint model for multistate disease processes and random informative observation times, with applications to electronic medical records data. Biometrics. 71: 90-101. PMID 25319319 DOI: 10.1111/Biom.12252 |
0.632 |
|
| 2015 |
Hubbard RA, Benjamin-Johnson R, Onega T, Smith-Bindman R, Zhu W, Fenton JJ. Classification accuracy of claims-based methods for identifying providers failing to meet performance targets. Statistics in Medicine. 34: 93-105. PMID 25302935 DOI: 10.1002/Sim.6318 |
0.325 |
|
| 2015 |
Hubbard RA, Zhu W, Balch S, Onega T, Fenton JJ. Identification of abnormal screening mammogram interpretation using Medicare claims data. Health Services Research. 50: 290-304. PMID 24976519 DOI: 10.1111/1475-6773.12194 |
0.305 |
|
| 2015 |
Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment. Pharmacoepidemiology and Drug Safety. 24: 75-85. PMID 24923811 DOI: 10.1002/Pds.3660 |
0.31 |
|
| 2015 |
Henderson L, Hubbard R, Wernli K, Kerlikowske K, Buist DS, Sprague B, Goodrich M, DeMartini W, Ozanne E, Zhu W, O'Donoghue C, Virnig BA, Tosteson AN, Onega T. Are breast density and family history associated with pre-operative breast MRI use? Journal of Clinical Oncology. 33: e17543-e17543. DOI: 10.1200/Jco.2015.33.15_Suppl.E17543 |
0.339 |
|
| 2014 |
Etzioni R, Xia J, Hubbard R, Weiss NS, Gulati R. A reality check for overdiagnosis estimates associated with breast cancer screening. Journal of the National Cancer Institute. 106. PMID 25362701 DOI: 10.1093/Jnci/Dju315 |
0.375 |
|
| 2014 |
Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM. Metabolic syndrome and outcomes following early-stage breast cancer. Breast Cancer Research and Treatment. 148: 363-77. PMID 25301086 DOI: 10.1007/S10549-014-3157-6 |
0.357 |
|
| 2014 |
Onega T, Weiss J, Kerlikowske K, Wernli K, Buist DS, Henderson LM, Goodrich M, Alford-Teaster J, Virnig B, Tosteson AN, DeMartini W, Hubbard R. The influence of race/ethnicity and place of service on breast reconstruction for Medicare beneficiaries with mastectomy. Springerplus. 3: 416. PMID 25140292 DOI: 10.1186/2193-1801-3-416 |
0.326 |
|
| 2014 |
Onega T, Hubbard R, Hill D, Lee CI, Haas JS, Carlos HA, Alford-Teaster J, Bogart A, DeMartini WB, Kerlikowske K, Virnig BA, Buist DS, Henderson L, Tosteson AN. Geographic access to breast imaging for US women. Journal of the American College of Radiology : Jacr. 11: 874-82. PMID 24889479 DOI: 10.1016/J.Jacr.2014.03.022 |
0.341 |
|
| 2014 |
Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, et al. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. Journal of the National Cancer Institute. 106: dju092. PMID 24872543 DOI: 10.1093/Jnci/Dju092 |
0.343 |
|
| 2014 |
Wernli KJ, Hubbard RA, Johnson E, Chubak J, Kamineni A, Green BB, Rutter CM. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1230-7. PMID 24793956 DOI: 10.1158/1055-9965.Epi-13-1360 |
0.331 |
|
| 2014 |
Fenton JJ, Zhu W, Balch S, Smith-Bindman R, Fishman P, Hubbard RA. Distinguishing screening from diagnostic mammograms using Medicare claims data. Medical Care. 52: e44-51. PMID 22922433 DOI: 10.1097/Mlr.0B013E318269E0F5 |
0.309 |
|
| 2013 |
O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 119: 3959-67. PMID 24037812 DOI: 10.1002/Cncr.28310 |
0.349 |
|
| 2013 |
Roman M, Hubbard RA, Sebuodegard S, Miglioretti DL, Castells X, Hofvind S. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results. Cancer. 119: 3952-8. PMID 23963877 DOI: 10.1002/Cncr.28320 |
0.358 |
|
| 2013 |
Fenton JJ, Onega T, Zhu W, Balch S, Smith-Bindman R, Henderson L, Sprague BL, Kerlikowske K, Hubbard RA. Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography. Medical Care. PMID 23929404 DOI: 10.1097/Mlr.0B013E3182A303D7 |
0.37 |
|
| 2013 |
Hubbard RA, Johnson E, Hsia R, Rutter CM. The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1612-9. PMID 23868091 DOI: 10.1158/1055-9965.Epi-13-0254 |
0.326 |
|
| 2013 |
Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI. Journal of General Internal Medicine. 28: 1454-62. PMID 23760741 DOI: 10.1007/S11606-013-2507-0 |
0.379 |
|
| 2013 |
Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. Jama Internal Medicine. 173: 807-16. PMID 23552817 DOI: 10.1001/Jamainternmed.2013.307 |
0.344 |
|
| 2013 |
Hubbard RA, Zhu W, Horblyuk R, Karliner L, Sprague BL, Henderson L, Lee D, Onega T, Buist DS, Sweet A. Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Breast Cancer Research and Treatment. 138: 879-87. PMID 23471650 DOI: 10.1007/S10549-013-2466-5 |
0.348 |
|
| 2013 |
Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? Journal of the National Cancer Institute. 105: 334-41. PMID 23385442 DOI: 10.1093/Jnci/Djs645 |
0.378 |
|
| 2013 |
Hubbard RA, Miglioretti DL. A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring. Biometrics. 69: 245-53. PMID 23383717 DOI: 10.1111/J.1541-0420.2012.01831.X |
0.364 |
|
| 2013 |
Wernli K, Hubbard R, Johnson E, Chubak J, Kamineni A, Rutter C. A2-1: Patterns of Colorectal Cancer Testing in Men and Women Newly Eligible for Screening Clinical Medicine & Research. 11: 123-123. DOI: 10.3121/Cmr.2013.1176.A2-1 |
0.35 |
|
| 2012 |
Hubbard RA, Zhu W, Onega TL, Fishman P, Henderson LM, Tosteson AN, Buist DS. Effects of digital mammography uptake on downstream breast-related care among older women. Medical Care. 50: 1053-9. PMID 23132199 DOI: 10.1097/Mlr.0B013E318269E9C2 |
0.354 |
|
| 2012 |
Henderson LM, Hubbard RA, Onega TL, Zhu W, Buist DS, Fishman P, Tosteson AN. Assessing health care use and cost consequences of a new screening modality: the case of digital mammography. Medical Care. 50: 1045-52. PMID 22922432 DOI: 10.1097/Mlr.0B013E318269E0D1 |
0.363 |
|
| 2012 |
Yasmeen S, Hubbard RA, Romano PS, Zhu W, Geller BM, Onega T, Yankaskas BC, Miglioretti DL, Kerlikowske K. Risk of advanced-stage breast cancer among older women with comorbidities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1510-9. PMID 22744339 DOI: 10.1158/1055-9965.Epi-12-0320 |
0.356 |
|
| 2012 |
Thorsen C, Weiss J, Kerlikowske K, Ozanne E, Buist D, Hubbard R, Tosteson A, Henderson L, Virnig B, Goodrich M, Onega T. Abstract P4-01-15: Impact of Preoperative MRI on the Surgical Treatment of Breast Cancer: A SEER-Medicare Analysis Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-01-15 |
0.35 |
|
| 2011 |
Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Annals of Internal Medicine. 155: 481-92. PMID 22007042 DOI: 10.1097/Ogx.0B013E31824B70A2 |
0.332 |
|
| 2011 |
Hubbard R, Kerlikowske K, Buist D, Yankaskas B. Evaluation of breast cancer screening strategies must be based on comparison of harms and benefits American Journal of Roentgenology. 197. PMID 21940562 DOI: 10.2214/Ajr.11.6791 |
0.369 |
|
| 2011 |
Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography Annals of Internal Medicine. 155: 481. DOI: 10.1059/0003-4819-155-8-201110180-00004 |
0.328 |
|
| 2010 |
Hubbard RA, Miglioretti DL, Smith RA. Modelling the cumulative risk of a false-positive screening test. Statistical Methods in Medical Research. 19: 429-49. PMID 20356857 DOI: 10.1177/0962280209359842 |
0.37 |
|
| 2009 |
Hubbard RA, Inoue LY, Diehr P. Joint modeling of self-rated health and changes in physical functioning. Journal of the American Statistical Association. 104: 912. PMID 20151036 DOI: 10.1198/Jasa.2009.Ap08423 |
0.6 |
|
| 2008 |
Hubbard RA, Inoue LY, Fann JR. Modeling nonhomogeneous Markov processes via time transformation. Biometrics. 64: 843-50. PMID 18047532 DOI: 10.1111/J.1541-0420.2007.00932.X |
0.603 |
|
| Show low-probability matches. |